Guru Ownership Trend
Guru Analysis for Catalyst Pharmaceuticals, Inc. (CPRX)
Catalyst Pharmaceuticals, Inc. (CPRX), a key player in the 医疗健康 sector, continues to attract institutional attention.
As of Q3 2025, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $234.55 M.
Top institutional holders include 文艺复兴科技 and 特里·史密斯.
Institutional sentiment is currently Bullish. This is evidenced by a $25.35 M net inflow during the quarter.
Recent activity highlights 乔尔·格林布拉特 who increased their stake by 28.8%. Conversely, 克里福德·阿斯尼斯 reduced exposure by 15.4%.
| Portfolio Manager | % Portfolio | Activity | Shares | Value | Report Date |
|---|---|---|---|---|---|
| 0.09% | Add 9.0% | 3,544,830 | $69.83 M | Q3 2025 | |
| 0.33% | Add 24.2% | 3,363,807 | $66.27 M | Q3 2025 | |
| 0.40% | Add 28.6% | 2,034,965 | $40.09 M | Q3 2025 | |
| 0.00% | Reduce -15.4% | 337,052 | $6.64 M | Q3 2025 | |
| 0.63% | 147,000 | $2.9 M | Q3 2025 | ||
| 0.01% | Add 28.8% | 141,343 | $2.78 M | Q3 2025 | |
| 0.00% | 83,137 | $1.64 M | Q3 2025 |
| Report Date | Portfolio Manager | Activity | Share Change | % Portfolio Change |
|---|
| Report Date | Portfolio Manager | Activity | Share Change | % Portfolio Change |
|---|
| Report Date | Portfolio Manager | Activity | Share Change | % Portfolio Change |
|---|
| Portfolio Manager | Option Type | % Portfolio | Activity | Shares | Value | Report Date |
|---|
Key Holders
Recent Activity Breakdown (Q3 2025)
Guru Consensus (Q3 2025)
FAQs for Catalyst Pharmaceuticals, Inc. (CPRX)
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $25.35 M, with 4 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited CPRX. The total reported sell value was $2.86 M.
Yes, 0 managers opened new positions in CPRX, and 4 increased their existing holdings. The total reported buy value was $28.21 M.